Mastech Holdings, Inc. 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report on Form 10-Q for the period ended March 31, 2010. Mastech Holdings, Inc. provides IT and specialized healthcare staffing services to large and medium-sized organizations. The company operates as a single reportable segment, tracking revenues across Wholesale IT, Retail IT, Specialized Healthcare, and Permanent Placements channels.
Key Financial Metrics
| Metric | Q1 2010 | Q1 2009 |
|---|---|---|
| Revenues | $15.7 million | $20.6 million |
| Gross Profit | $3.1 million | $3.8 million |
| Gross Margin | 19.6% | 18.7% |
| Net Income | $63,000 | $495,000 |
| Earnings Per Share (Diluted) | $0.02 | $0.14 |
| Cash and Equivalents | $6.3 million | $5.6 million (end of period) |
| Operating Cash Flow | $0.3 million | $1.3 million |
| Total Debt | $125,000 | $0 |
Material Changes vs. Prior Period
- Revenue Decline: Revenues decreased 23.5% year-over-year to $15.7 million. This was driven by a lower level of billable IT consultants (389 in Q1 2010 vs. 492 in Q1 2009) and the divestiture of the brokerage operations unit (GFS) in January 2010.
- Margin Expansion: Despite lower revenues, gross margin improved to 19.6% from 18.7%. This improvement is attributed to the sale of the lower-margin brokerage unit and a favorable mix of higher-margin integrator clients in the Wholesale IT channel.
- Profitability Drop: Net income fell to $63,000 from $495,000 due to the revenue decline and increased Selling, General, and Administrative (SG&A) expenses as a percentage of revenue (18.8% vs. 14.5%).
- Acquisition Activity: The company acquired Curastat, Inc. in January 2010 for an estimated $1.27 million, diversifying into specialized healthcare staffing. This resulted in a $1.3 million cash outflow for investing activities.
Guidance, Outlook, and Risks
- Outlook: Management notes encouraging improvements in business activity levels in Q1 2010 but cites the weak U.S. job market and high unemployment as ongoing concerns. The company expects cash from operations to be adequate for business needs, excluding acquisition activities.
- Client Concentration: Revenue concentration decreased; the top ten clients represented 53% of revenue in Q1 2010 compared to 68% in Q1 2009. IBM remained the largest single client at 18.8% of total revenue.
- Risks: The company faces risks related to economic conditions, client concentration, and the shift toward Managed Service Providers (MSPs) in the retail channel, which may exert downward pressure on gross margins.
- Contingencies: The company is involved in various lawsuits and administrative proceedings, though management does not expect a material adverse effect on financial position.
Investor Verification Checklist
- Verify the sustainability of the 10-consultant increase in billable IT headcount, as this is the first growth since mid-2006.
- Monitor the integration and revenue contribution of the newly acquired Curastat, Inc. healthcare unit.
- Assess the impact of the divestiture of the brokerage unit on future revenue stability.
- Review the aging of accounts receivable, as Days Sales Outstanding (DSO) increased to 48 days from 44 days.
- Track the contingent earn-out component of the Curastat acquisition, which ranges up to $226,000 based on future EBITDA.